Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study
← catalyst calendarNCT05991323 · readout in 34 d
Sponsored by Sanofi (industry) · SNY — their whole pipeline →. With Regeneron Pharmaceuticals.
Phase
—
Status
Active, not recruiting
Study type
Observational
Enrollment
100estimated
Sites
49
Countries
Canada, China, France +3
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2023-12-12 | actual | When the study began enrolling |
| Primary completion | 2026-09-22 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2026-09-22 | estimated | The whole study's end, after follow-up |
| First posted | 2023-08-14 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-09-16 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Prurigo Nodularis
Intervention
- Drug: Dupilumab — also filed as DUPIXENT, SAR231893
Primary outcomes
what the primary-completion date above is the date OFFrequency of reasons for dupilumab treatment initiation with the description of dosing, frequency and duration of treatment
measured At baseline
Frequency of reasons for dupilumab treatment modifications with the description of the modified treatment
measured From baseline up to month 18
Proportion of patients who discontinued dupilumab
measured From baseline up to month 18
Frequency of reasons for dupilumab treatment discontinuation
measured From baseline up to month 18
Proportion of patients hospitalized due to PN
measured From baseline up to month 18
Permalink · SNY's whole pipeline · Catalyst calendar · Every registered study · What changed